July 10, 2013 at 19:11 PM EDT
GTx Expected To Disappoint
TheStreet expects GTx Inc. (Nasdaq: GTX) to report disappointing results from two Phase III studies of its muscle wasting drug enobosarm sending the stock price tumbling $1.75 to close at $5.20.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here